NDRG1 facilitates self-renewal of liver cancer stem cells by preventing EpCAM ubiquitination.

Our findings suggest that NDRG1 enhances CSCs expansion, PVTT formation and growth capability through the regulation of EpCAM stability. NDRG1 may be a promising target for the treatment of patients with HCC and PVTT.